Biotechnology News
Press Releases from Biotechnology Companies
Newsroom
Biotechnology news releases from biotechnology companies published by Newsfile. Searches will return results from stories up to two years old.
-
Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that in connection with its previously announced "bought deal" public offering (the "Offering") underwritten by Canaccord Genuity Corp. (the "Lead Underwriter"), as lead underwriter and...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-04-19 9:36 AM EDT | Mindset Pharma Inc. -
Awakn Life Sciences Inc. Announces Two Key Appointments to Its Board of Directors
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Awakn Life Sciences Inc. (Awakn), a biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat addiction, announced today the appointment of Stephen Page and Professor John Papastergiou as independent non-executive directors to the Company's Board of Directors....
Biotechnology, Healthcare and Hospitals, Health
2021-04-19 9:17 AM EDT | Awakn Life Sciences Inc. -
Psygen Industries Ltd. and 1290442 B.C. Ltd. Announce Execution of Definitive Agreement for Reverse Takeover Transaction
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - Further to the press release of Psygen Industries Ltd. ("Psygen") and Larose Ventures Ltd. dated March 24, 2021, Psygen and 1290442 B.C. Ltd. ("1290") are pleased to announce they have entered into an amalgamation agreement (the "Amalgamation Agreement") dated April 16,...
Biotechnology, Pharmaceuticals
2021-04-19 8:00 AM EDT | PsyGen Industries Ltd. -
Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has received CE approval certification from an EU competent authority...
Technology, Biotechnology, Health
2021-04-19 8:00 AM EDT | Therma Bright Inc. -
Universal PropTech Inc. Announces Option Grant
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - Universal PropTech Inc. (TSXV: UPI) (FSE: 8LH) ("UPI" or "the Company") announces today that it has granted 100,000 options to an employee pursuant to the Company's stock option plan. The stock options vest in the following schedule: 30% immediately, 30% on...
Biotechnology, Environmental Services, Energy, Utilities
2021-04-16 4:30 PM EDT | Universal PropTech Inc. -
American Aires Inc. Responds to OTC Markets Request on Recent Promotional Activity
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - American Aires Inc. (CSE: WIFI) (the "Company") announces that it has been requested by OTC Markets Group Inc. ("OTC Markets") to issue this statement about promotional activity concerning its common stock.On Tuesday, April 13, 2021, OTC Markets informed the Company that it...
Technology, Biotechnology
2021-04-16 4:26 PM EDT | American Aires Inc. -
Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange
Westport, Connecticut--(Newsfile Corp. - April 16, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that it plans to voluntarily delist its common shares ("Shares") from the Canadian Securities Exchange...
Biotechnology, Pharmaceuticals
2021-04-16 9:00 AM EDT | Portage BioTech Inc. -
Relay Medical & Fio Address COVID-19 Vaccines, Variants and the Continued Need for Widespread Rapid Testing
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio") together through their joint venture company, Fionet Rapid Response Group ("FRR") report on recent news related to the impact of COVID-19 vaccinations, emerging new variants...
Biotechnology, Healthcare and Hospitals, Health
2021-04-16 3:00 AM EDT | Relay Medical Corp. -
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that it has completed the previously announced "bought deal" public offering through the issuance of an aggregate of 10,000,000 units (each, a "Unit") of the...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-04-15 9:10 AM EDT | Mindset Pharma Inc. -
Nextleaf Solutions Awarded U.S. Patent for Synthesizing THC-O-Acetate
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2021) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), the world's most innovative cannabis processor, is pleased to announce that the United States Patent and Trademark Office has granted the Company a patent pertaining to a...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2021-04-15 9:00 AM EDT | Nextleaf Solutions Ltd. -
Relay Medical and Fio Partner with LifeLabs to Deploy Fionet Platform for COVID-19 Rapid Testing Nationwide
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio") together through their joint venture company, Fionet Rapid Response Group ("FRR"), announce the execution of an agreement with LifeLabs LP ("LifeLabs") to deploy the Fionet...
Biotechnology, Healthcare and Hospitals, Health
2021-04-15 9:00 AM EDT | Relay Medical Corp. -
Annovis Bio Appoints Reid McCarthy to Board and to Role of Audit Committee Chairman
Berwyn, Pennsylvania--(Newsfile Corp. - April 15, 2021) - Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the appointment of Reid S. McCarthy to its Board of Directors and to the role of Audit Committee chairman,...
Biotechnology, Pharmaceuticals
2021-04-15 7:30 AM EDT | Annovis Bio, Inc. -
MustGrow Outlines Upcoming Investment Conferences
Saskatoon, Saskatchewan--(Newsfile Corp. - April 15, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness...
Biotechnology, Cannabis, Cannabis Breeder, Cannabis Cultivator
2021-04-15 7:02 AM EDT | MustGrow Biologics Corp. -
American Aires Announces Creation of Advisory Board
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - American Aires Inc. (CSE: WIFI) (the "Company") is pleased to announce that it has established an Advisory Board and that Dr. Arturas Jukna, Dr. Gennadi Lukyanov and Dr. Nataliya Dyuzhikova have been appointed as its initial members to assist the Company in...
Technology, Biotechnology
2021-04-15 7:00 AM EDT | American Aires Inc. -
Tryp Therapeutics to Host Investor Day on April 22
San Diego, California--(Newsfile Corp. - April 15, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it will be hosting its quarterly Investor Day on Thursday, April...
Biotechnology, Pharmaceuticals
2021-04-15 7:00 AM EDT | Tryp Therapeutics Inc. -
ScreenPro Security Opens its First COVID-19 Testing Walk-In Clinic in Vancouver
Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - ScreenPro Security Inc., (CSE: SCRN) ("ScreenPro" or the "Company") is pleased to announce that it has opened its first COVID-19 testing clinic in partnership with Concierge Medical Consultants, Inc. ("Concierge"), located in Coal Harbor, Vancouver. The clinic is operated by Concierge...
Technology, Biotechnology
2021-04-15 3:00 AM EDT | ScreenPro Security Ltd. -
American Aires Provides Clarity on the Fourth Quarter Revenue Press Release Issued February 11, 2021
Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - American Aires Inc. (CSE: WIFI) (the "Company" or "Aires") a nanotechnology-focused disruptor focused on developing products that reduce the harmful effects of electromagnetic radiation ("EMR") emitted by everyday consumer electronic devices, would like to clarify the press release issued February 11...
Technology, Biotechnology
2021-04-14 5:15 PM EDT | American Aires Inc. -
Relay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing Nationwide
Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio") together through their joint venture company, Fionet Rapid Response Group ("FRR"), announce the execution of an agreement with LifeLabs LP ("LifeLabs") to deploy the Fionet...
Biotechnology, Healthcare and Hospitals, Health
2021-04-14 5:02 PM EDT | Relay Medical Corp. -
Cloud DX Inc. Announces Option Grants and Escrow Amendments
Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - Cloud DX Inc. (TSXV: CDX) (formerly Roosevelt Capital Group Inc.) ("Cloud DX" or the "Company") announces that the Company's board of directors has authorized the issuance of stock options under its stock option plan to purchase 4,604,963 Common Shares at an exercise...
Technology, Biotechnology, Healthcare and Hospitals
2021-04-14 12:45 PM EDT | Cloud DX Inc. -
NervGen Pharma Receives Ethics Approval to Initiate Phase 1 Clinical Trial for NVG-291
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, has received approval and guidance from the Bellberry Human Research Ethics Committee ("HREC")...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-04-14 8:30 AM EDT | NervGen Pharma Corp.